Skip to content
Screener

Beta Bionics BBNX Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$23.4M-38.7%-$21.9M+23.6%-$13.47M+25.6%-$14.21M-45.9%-$16.87M-16.6%
$709K+104%$585K+93.1%$538K+132%$385K+15.6%$347K+16.1%
$7.02M+46.2%$5.41M+92.8%$4.3M+177%$4.48M+127%$4.8M+220%
-$14.62M-7.6%-$23.83M-19.3%-$8.63M+39.6%-$8.73M+9.2%-$13.59M-11.1%
$1.04M-41.6%$1.38M+314%$1.9M+239%$1.28M-33.3%$1.78M+251%
$26.93M$21.84M+112%
$1.8M+4,188%$623K-99.7%$1.06M-98.1%$2.65M+326%$42K+139%
$14.11M-$1.37M-111%$3.41M-23.4%
-$15.66M-1.9%-$25.21M-24.1%-$10.53M+29.0%-$10.01M+13.2%-$15.37M-20.6%

FAQ

How much cash does Beta Bionics generate?
Beta Bionics (BBNX) generated -$55.8M in operating cash flow over the trailing twelve months.
What is Beta Bionics's free cash flow?
After $5.6M of capital expenditures, Beta Bionics's free cash flow was -$61.4M over the trailing twelve months, up 1.0% year over year.
Where does Beta Bionics's cash flow data come from?
Every line is extracted from Beta Bionics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.